• 3DC

  Participated · Series A · Aug 2025

  3DC develops and manufactures Graphene MesoSponge® (GMS), a three-dimensional graphene material with porosity, conductivity, flexibility, and corrosion resistance intended to address trade-offs in battery performance. The company was founded in February 2022 and is headquartered at Tohoku University in Sendai, with a Kawasaki office and a pilot factory in Toki, Gifu where construction of the world’s first GMS mass-production facility has begun. Following a Series A 1st-close in August 2025 and ongoing validation work, 3DC is supplying functional conductive additive GMS to numerous domestic and international battery makers for evaluation. 3DC plans to use recent and prior funding to expand its pilot factory into a mass-production plant, establish ton-scale production processes, strengthen global supply for customer evaluations and commercialization, and expand R&D talent and overseas partnerships. The company positions partnerships with established industry players and strategic investors as key to accelerating production, supply-chain stabilization, and market adoption of GMS.

• Rege Nephro

  Participated · Series B · Oct 2024

  Rege Nephro is developing therapies for kidney disease and is advancing a clinical pipeline in the renal space. The company is preparing for clinical trials and is using interim financing to accelerate R&D and pipeline advancement. Its recent bridge financing is intended to extend cash runway and de-risk near-term development milestones ahead of a larger Series C. Rege Nephro says this capital raise is part of a longer-term strategy to strengthen its position in renal therapies. The company plans to pursue a Series C in autumn 2026 and beyond as it progresses clinical and development activities.

• DAIZ

  Participated · Series B · Apr 2021

  DAIZ develops plant-based meats and fish built on its proprietary Ochiai high-pressure process that converts germinated soybeans into “miracle chips” for improved texture and flavor without additives. The company is positioning its product as part of a consumer “hybrid strategy,” supplying both domestic and international retail, distribution, food manufacturing, and restaurant customers. DAIZ has partnerships to expand its ingredient base, including a collaboration with France’s Roquette to produce a pea-based version and plans for a future “Miracle Egg” product. The company plans to use the Series C proceeds to build a new 40,000-square-foot plant in Kumamoto Rinku Techno Park, scheduled to launch in February 2025, with initial capacity of 8,000 tons in year one and eventual expansion to 20,000 tons per year. DAIZ has received backing from 33 companies, including 17 listed companies, and says the financing brought its total capital raised to ¥13.1 billion (about US$86.5 million), the largest amount in Japan’s domestic food tech industry. Management highlighted that ministry-backed loan programs enabled long-term, low-cost corporate loans that supplemented equity financing for this expansion. DAIZ develops MIRACLE MEAT, a plant-based meat substitute made from whole germinated soybeans using the Ochiai Germination Method (OGM) to boost taste, nutritional value, and nutrient absorbency while reducing beany off-flavors. MIRACLE MEAT aims to mimic the taste and texture of meat and has been adopted by multiple food manufacturers and restaurant chains, primarily in Japan. The company emphasizes sustainable protein production with lower greenhouse‑gas emissions compared with livestock, and positions its product as a solution for increasing global protein demand. DAIZ intends to expand domestic and overseas adoption of its plant-based meat and contribute to sustainable agricultural production and food supplies. Through a partnership with Mitsubishi Chemical Holdings, DAIZ expects technological synergies—particularly in food additives and emulsifiers—to further improve MIRACLE MEAT’s flavor. The company was established December 1, 2015 and is headquartered in Kumamoto‑shi, Kumamoto Prefecture. DAIZ Inc. announced a ¥1,850,000,000 Series B round on April 19, 2021. The capital was raised via a third-party capital increase (equity). The transaction included participation from a broad group of existing, new, and returning investors. Existing investors named include Ajinomoto Co., Kichiri & Co., and the Norinchukin Bank investment arm. New investors listed include Nippon Steel Trading Corporation, KANEMATSU FOODS CORPORATION, Kanematsu Corporation, ENEOS Innovation Partners LLC, Marubeni Corporation, Shinkin Capital Co., Kemuri Ventures LLC, Kirin Holdings Company, Mitsui Sumitomo Insurance Venture Capital Co., Global Brain Co., and Golden Asia Fund Venture Ltd. Returning and other participants included Mitsubishi UFJ Capital Co., Ltd., Marubeni Corporation, and QB Capital, LLC. Daiz is a Japanese startup developing plant-based substitutes for meat products. It produces plant-based meat alternatives. The company has raised ¥650 million in a Series A funding round. That amount is approximately $6 million. The round was backed by Mitsubishi UFJ Capital (Mucap). The financing was disclosed as a Series A round.

• Floadia

  Participated · Series B · Jul 2017

  Floadia develops and licenses embedded non-volatile flash memory IP cores used in microcontrollers, power semiconductors, sensors and other chips. Its technology reportedly consumes only 1/1,000,000 of the power required to write and erase data versus competitors, offers strong high-temperature tolerance, and adds only one-third of the additional integration cost. Its first flash IP, “G1,” is deployed in automotive microcontrollers by domestic semiconductor manufacturers and has been adopted by a Taiwanese foundry for smartphone components. Founded in 2011 by engineers with long experience at Hitachi and Renesas, the company focuses on ultra-low-power memory technology. Floadia plans to use the new funding to strengthen sales of its embedded flash IP to semiconductor manufacturers and to advance development of ultra-low-power AI accelerator chips that utilize its flash memory devices. The company has raised a cumulative total of approximately ¥4.95 billion to date. Floadia develops embedded non-volatile memory IP and the associated manufacturing processes and circuit designs that enable integration into microcontrollers, power semiconductors, sensors and other semiconductor devices. Its memories reduce power consumption and cost, offer auto-grade heat endurance, and can be embedded without changing existing IP designs to ease analog/digital integration. Floadia's technology has been adopted in in-vehicle microcomputers and Toshiba microcontrollers and is used for smartphone components produced by Taiwanese foundries. The company is working with major foundries to transplant its technology onto the 130nm BCD Plus platform and planned mass production from early 2021. Founded in 2011 by engineers who left Renesas Electronics, Floadia is based in Kodaira-shi, Tokyo. Financially, the company raised approximately ¥1.2 billion in its Series C and has raised about ¥3.6 billion in total to date. Floadia Corporation develops embedded flash memory IP, licensing manufacturing process know-how and circuit designs for embedded non-volatile memory production. Founded in 2011 by engineers from Renesas Electronics and led by President Kosuke Okuyama, the company is based in Tokyo, Japan. Its core product is embedded flash memory IP intended for integration into semiconductor manufacturing. Floadia plans to use the new funds to expand its embedded flash IP business into automotive, low-cost IoT and mobile device markets. Financially, the company closed a ¥1.6 billion (approx. US$14.5M) Series B and had previously raised ¥800 million (US$7.3M) in a 2015 Series A. The business model centers on licensing IP to enable customers to produce embedded non-volatile memory.

• WHILL

  Participated · Series B · May 2016

  WHILL designs and sells high-tech personal mobility devices intended for both indoor and outdoor use. The company’s products include the less expensive Model Ci (called Model C in Europe and Japan) and compete with devices like iBot and Trackchair. WHILL is developing autonomous capabilities and building its own sensors and cameras to support a “mobility as a service” program that lets users summon and control vehicles via a mobile app. Key near-term plans include expanding into the EU (opening a branch and entering 10 new European countries) and deploying systems in large venues such as airports, shopping malls, and sports arenas. WHILL has tested an autonomous airport program in partnership with Panasonic and plans to pursue distribution partnerships with U.S. airlines and airports. In Japan the company has between 4,000 and 5,000 resellers, its devices are subsidized and available for rent, while U.S. customers often buy devices out-of-pocket. Whill produces high-tech motorized wheelchairs, notably the Model M and Model A. Its products use a patented wheel that enables tight turns on rough terrain and sloping surfaces. The company recently received FDA approval for the Model M, allowing it to be marketed as a medical device in the U.S. and enabling doctors to write prescriptions starting this summer. Whill plans to use Series B proceeds to market its devices in the U.S. and to enter the European market, and it launched an airport rental program last month. It is developing technologies for autonomous driving and remote management of its devices to differentiate from competitors. Founded four years ago in Tokyo and now headquartered in San Francisco, Whill has raised $30.2 million in venture funding to date. Whill makes personal mobility devices designed for indoor use and all-terrain outdoor travel, featuring All Direction 4WD and an advanced acceleration management system for full-range speed adjustment. The product line was founded and designed by former Toyota and Nissan industry experts and engineers and is led by CEO Satoshi Sugie. Whill plans to use recent funding to manufacture and expand distribution of its devices and to grow overall operations. The company has won recognition, including the TechCrunch Tokyo 2012 Grand Prize. Financially, Whill closed an $11M Series A to support its manufacturing and distribution expansion. Whill develops the WHILL, a next-generation electric personal mobility vehicle intended for sidewalks and for healthy users as well as mildly disabled or elderly people with difficulty walking. The company is based in Menlo Park, California and was founded in May 2012; it is led by CEO Satoshi Sugie. Whill received funding to continue development and production of its WHILL vehicle. The company plans an initial direct sale of 50 units to the US market, followed by sequential expansion into other countries including Japan. Backers named in the article include SunBridge Global Ventures (via SunBridge Startups), Itochu Technology Ventures, 500 Startups and WIngle Co., Ltd. The article did not disclose financial terms, revenue, or instrument types.

No current team members are available.